...
首页> 外文期刊>Scientific reports. >Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus
【24h】

Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus

机译:细胞内寡聚淀粉样蛋白β快速调节海马AMPA受体的Glua1亚基

获取原文

摘要

The acute neurotoxicity of oligomeric forms of amyloid-β 1-42 (Aβ) is implicated in the pathogenesis of Alzheimer’s disease (AD). However, how these oligomers might first impair neuronal function at the onset of pathology is poorly understood. Here we have examined the underlying toxic effects caused by an increase in levels of intracellular Aβ, an event that could be important during the early stages of the disease. We show that oligomerised Aβ induces a rapid enhancement of AMPA receptor-mediated synaptic transmission (EPSCA) when applied intracellularly. This effect is dependent on postsynaptic Ca2+ and PKA. Knockdown of GluA1, but not GluA2, prevents the effect, as does expression of a S845-phosphomutant of GluA1. Significantly, an inhibitor of Ca2+-permeable AMPARs (CP-AMPARs), IEM 1460, reverses the increase in the amplitude of EPSCA. These results suggest that a primary neuronal response to intracellular Aβ oligomers is the rapid synaptic insertion of CP-AMPARs.
机译:淀粉样蛋白-β1-42(Aβ)的低聚形式的急性神经毒性涉及阿尔茨海默病(AD)的发病机制。然而,这些低聚物可能首先在病理学发生时首先损害神经元功能是较差的理解。在这里,我们研究了由于细胞内Aβ水平增加而导致的潜在毒性效应,这是在疾病的早期阶段可能重要的事件。我们表明,在细胞内施用时,低聚Aβ诱导AMPA受体介导的突触透射(EPSC A )的快速增强。这种效果取决于突触后Ca 2 + 和pka。 Glua1的敲低,但不是Glua2,防止了Glua1的S845-膦仿效的效果。值得注意的是,Ca 2 + -MPARS(CP-AMPAR),IEM 1460的抑制剂反转EPSC A 的增加。这些结果表明对细胞内Aβ低聚物的主要神经元反应是CP-AMPars的快速突触插入。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号